Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)

$49.14

+0.21 (+0.43%)

(As of 04/22/2024 ET)

Bristol-Myers Squibb Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 19 Analyst Ratings

Analysts' Consensus Price Target

$61.18
24.49% Upside

High Forecast	$85.00
Average Forecast	$61.18
Low Forecast	$50.00

Type	Current Forecast 4/24/23 to 4/23/24	1 Month Ago 3/25/23 to 3/24/24	3 Months Ago 1/24/23 to 1/24/24	1 Year Ago 4/24/22 to 4/24/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	7 Buy rating(s)
Hold	15 Hold rating(s)	15 Hold rating(s)	14 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$61.18	$61.12	$62.41	$80.00
Predicted Upside	24.49% Upside	12.72% Upside	11.12% Upside	10.43% Upside

Get Bristol-Myers Squibb Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

Ad Insider Financial

Thousands of investors use this no cost solution | Do you?

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"

BMY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BMY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bristol-Myers Squibb Stock vs. The Competition

Type	Bristol-Myers Squibb	Medical Companies	S&P 500
Consensus Rating Score	2.11	2.68	2.49
Consensus Rating	Hold	Moderate Buy	Hold
Predicted Upside	24.49% Upside	1,013.25% Upside	11.07% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/18/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$51.00 ➝ $52.00	+8.11%
4/1/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Phipps Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
3/11/2024	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
2/6/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$77.00 ➝ $54.00	+12.50%
1/3/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$68.00 ➝ $60.00	+13.67%
11/15/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	O. Brayer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$68.00 ➝ $55.00	+8.86%
Get the Latest News and Ratings for BMY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bristol-Myers Squibb and its competitors with MarketBeat's FREE daily newsletter.
11/9/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$55.00	+4.92%
11/2/2023	Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$68.00 ➝ $54.00	+5.30%
10/30/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$81.00 ➝ $69.00	+35.48%
10/27/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underweight ➝ Underweight	$56.00 ➝ $50.00	-5.63%
10/27/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$60.00 ➝ $51.00	-3.75%
10/27/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$60.00	+13.24%
10/27/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Reduce ➝ Hold	$55.00 ➝ $53.00	+0.03%
10/20/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral	$70.00 ➝ $60.00	+6.29%
10/6/2023	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$84.00	+47.91%
9/15/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$80.00 ➝ $66.00	+11.47%
7/28/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight	$90.00 ➝ $85.00	+39.89%
7/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$72.00 ➝ $66.00	+5.13%
7/10/2023	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Risinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
7/10/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$66.00	+5.35%
4/28/2023	51job Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 08:07 AM ET.

BMY Price Target - Frequently Asked Questions

What is Bristol-Myers Squibb's consensus rating and price target?: According to the issued ratings of 19 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 15 hold ratings and 3 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $61.18 with a high price target of $85.00 and a low price target of $50.00. Learn more on BMY's analyst rating history.
Do Wall Street analysts like Bristol-Myers Squibb more than its competitors?: Analysts like Bristol-Myers Squibb less than other Medical companies. The consensus rating for Bristol-Myers Squibb is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how BMY compares to other companies.
Is Bristol-Myers Squibb being downgraded by Wall Street analysts?: Over the previous 90 days, Bristol-Myers Squibb's stock had 2 downgrades by analysts.

Does Bristol-Myers Squibb's stock price have much upside?: According to analysts, Bristol-Myers Squibb's stock has a predicted upside of 13.01% based on their 12-month stock forecasts.
What analysts cover Bristol-Myers Squibb?: Bristol-Myers Squibb has been rated by Redburn Atlantic, Societe Generale, Wells Fargo & Company, and William Blair in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NYSE:BMY) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

Bristol-Myers Squibb Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

BMY Analyst Ratings By Month

BMY Price Targets by Month

Bristol-Myers Squibb Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

BMY Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info